Get one blood test. Detect up to 10, 20 or even more types of cancer.
That is the potential for a new category of cancer early detection tests currently being developed and tested by scientists. A breakthrough like this could revolutionize the ability to detect cancer at its earliest, most treatable stages, including for dozens of cancers for which there is no current screening test.
They call it a Multi-Cancer Early Detection (MCED) test. We call it an innovative and potentially game-changing advancement for cancer patients.
Now we need to ensure that, if approved by the FDA and shown to have clinical benefit, millions of people, especially older Americans at higher risk for cancer, will have the test covered by their health insurance plan. We are asking Congress to pass legislation that lays the groundwork for this to happen.